Literature DB >> 6482917

Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia.

F Meunier-Carpentier, R Snoeck, J Gerain, C Muller, J Klastersky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482917     DOI: 10.1056/NEJM198410183111617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients.

Authors:  Z Erjavec; G M Woolthuis; H G de Vries-Hospers; W J Sluiter; S M Daenen; B de Pauw; M R Halie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

3.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 4.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

5.  Invasive aspergillosis of the nose and paranasal sinuses in immunocompromised children.

Authors:  C Rotstein
Journal:  CMAJ       Date:  1988-08-15       Impact factor: 8.262

6.  Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies.

Authors:  G Todeschini; C Murari; R Bonesi; G Pizzolo; G Amaddi; A Ambrosetti; S Cerù; I Piacentini; N Martini; P Montresor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

7.  Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.

Authors:  B Hertenstein; W V Kern; T Schmeiser; M Stefanic; D Bunjes; M Wiesneth; J Novotny; H Heimpel; R Arnold
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.